Delivery Order SPE2DB22D1041-SPE2DB24FTZY4

Award Date 2/26/24
Potential Completion Date 2/27/24
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $2,566.57 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of M-M-R II vaccine vials. This order was placed under an existing indefinite delivery contract with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The $1,024.76 award has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the supply of M-M-R II vaccine vials. The $1,537.14 award has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The $1,750.61 order, which has a completion date of January 23, 2024, is for the supply of pharmaceutical products to support DLA Troop Support Medical facilities. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing a range of pharmaceutical and medical supplies to the Department...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,170.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract worth $5,123.90 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of M-M-R II vaccine vials, a critical medical product, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The delivery order has a potential value of $2,996.08 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which does not have a set-aside designation. The company also holds an indefinite delivery contract (IDC) with a potential value of...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $17,893.02 by the Defense Logistics Agency (DLA) for the delivery of M-M-R II vaccine vials. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00, to provide a broad range of pharmaceutical products and medical supplies in support of military treatment programs and...
The Defense Logistics Agency (DLA) awarded a $4,257.26 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is the prime contractor and serves as a key supplier of pharmaceuticals and medical supplies to DLA Troop Support Medical in support of military treatment programs and...
Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, has been awarded a firm fixed price Delivery Order contract by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The contract has a potential value of $1,537.14 and a period of performance through March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not associated with any set-aside designation. The...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FTZY4
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,347.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of M-M-R II vaccine vials and has a completion date of February 27, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies in support of military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this contract.

Generated 6/2/24, 12:10 AM